Company Profile

IPCA LABORATORIES LTD.

NSE : IPCALABBSE : 524494ISIN CODE : INE571A01020Industry : Pharmaceuticals & DrugsHouse : Ipca Laboratories
BSE1394.706.6 (+0.48 % )
PREV CLOSE (Rs.) 1388.10
OPEN PRICE (Rs.) 1384.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 19253
TODAY'S LOW / HIGH (Rs.)1371.40 1454.95
52 WK LOW / HIGH (Rs.)844.2 1615.7
NSE1397.75 5.5 (+0.4 % )
PREV CLOSE(Rs.) 1392.25
OPEN PRICE (Rs.) 1380.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1397.75 (1161 )
VOLUME 835497
TODAY'S LOW / HIGH(Rs.) 1367.00 1456.15
52 WK LOW / HIGH (Rs.)844.65 1622

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.22
TTM EPS (Rs.) 50.19
P/E Ratio 27.79
Book Value (Rs.) 285.83
Face Value (Rs.) 2
MCap (Rs. in Mn) 176223.29
Price/Earning (TTM) 21.78
Price/Sales (TTM) 4.20
Price/Book (MRQ) 4.88
PAT Margin (%) 12.52
ROCE (%) 16.76
Incorporation Year : 1949

Management Info :

Premchand Godha - Chairman Premchand Godha - Managing Director

Registered Office :

Address : 48 , Kandivli Industrial Estate,Kandivli (West), ,
Mumbai,
Maharashtra-400067

Phone : 022- 66474444

Website : www.ipcalabs.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
23Mar03-23-2020$Healthcare Services industry stocks trade higher on the bourses Healthcare Services industry

Healthcare Services industry stocks were trading higher after the government approved Rs 13,760 crore package to boost production of bulk drugs, medical devices.

Ipca Laboratories is currently trading at Rs 1407.95, up by 36.10 points or 2.63% from its previous closing of Rs. 1371.85 on the BSE. The scrip opened at Rs. 1485.00 and has touched a high and low of Rs. 1615.70 and Rs. 1269.90 respectively. So far 38757 shares were traded on the counter.

Thyrocare Technologies is currently trading at Rs 530.00, up by 24.25 points or 4.79% from its previous closing of Rs 505.75 on the BSE. The scrip opened at Rs 519.90 and has touched a high and low of Rs. 574.00 and Rs 490.00 respectively. So far 25277 shares were traded on the counter.

Minister of State for Chemicals and Fertilisers Mansukh Mandaviya has said that the government has approved four schemes with an incentive outlay of Rs 9,940 crore and Rs 3,820 crore for bulk drugs and medical devices respectively, to boost their domestic production in the country and exports. He said the Cabinet also approved a sum of Rs 3,000 crore for the next five years for the scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks.

Mandaviya also stated that a sum of Rs 6,940 crore has been approved for the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country. He said the PLI scheme will lead to expected incremental sales of Rs 46,400 crore and significant additional employment generation over eight years. He added that the scheme for promotion of medical device parks seeks to promote medical device parks in the country in partnership with the states.

The minister further said that a maximum grant-in-aid of Rs 100 crore per park will be provided to the states. It will have financial implications of Rs 400 crore. He noted that the PLI scheme for promoting domestic manufacturing of medical devices with financial implications of Rs 3,420 crore and the expenditure to be incurred for the schemes on promotion of medical devices will be for the next five years.


Healthcare Services industry stocks were trading higher after t..
28Feb02-28-2020$Ipca Laboratories informs about analysts meeting Ipca Laboratories informs ab

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has informed that the Company is organizing a group meeting of Analysts/ Institutional Investors with the Company's management on 28th February, 2020 at its Mumbai office. In this meeting, only publicly available information will be shared with the Analysts/ institutional investors.

The above information is a part of company’s filings submitted to BSE.

 

Pursuant to Regulation 30 of the SEBI (Listing Obligations and..
12Feb02-12-2020$ Corporate Action-Board approves Dividend Corporate Action-Board appr
We wish to inform you that the Board has declared an interim dividend of Rs. 5/- per share (250%) for the financial year 2019-20. Kindly note that vide our letter dated 4th February, 2020, we have already informed you that 20th February, 2020 has been fixed as the Record Date for ascertaining the members entitlement of said interim dividend now declared which will be paid by the Company to the eligible shareholders on or before 28th February, 2020.
We wish to inform you that the Board has declared an interim di..
04Feb02-04-2020$ Announcement under Regulation 30 (LODR)-Dividend Updates Announcement under Regulati
Pursuant to Regulation 29 read with Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a further notice is hereby given that at the said Board meeting, the Board will also consider declaration of Interim Dividend for the financial year 2019-20. We further wish to inform you that the Company has decided to fix 20th February, 2020 as the ''Record Date'' for the Members entitlement of interim dividend for the financial year 2019-20 that may be declared at the said Board Meeting on 12th February, 2020.
Pursuant to Regulation 29 read with Regulation 42 of the Securi..
23Jan01-23-2020$ Announcement under Regulation 30 (LODR)-Acquisition Announcement under Regulati
Approval of Resolution Plan submitted by Ipca Laboratories Ltd (the Company) for M/s. Noble Explochem Ltd by the Hon''ble National Company Law Tribunal, Mumbai
Approval of Resolution Plan submitted by Ipca Laboratories Ltd..
Financials More
Rs. in Millions
QTR Dec 19 ANNUAL 19
Net Profit1966.34549.1
Gross Profit 2331.1 5573.9
Operating Profit 2830.77477.6
Net Sales 11390.736331.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Sanofi India (BSE)
 6483.75 (3.87%)
M.Cap ( in Cr)
14932.48
Abbott India (BSE)
 15639.50 (1.19%)
M.Cap ( in Cr)
33232.85
Hester Biosciences (BSE)
 951.70 (2.88%)
M.Cap ( in Cr)
809.60
Procter&Gamble Healt (BSE)
 3669.75 (0.69%)
M.Cap ( in Cr)
6091.56
NGL Fine-Chem (BSE)
 274.45 (8.33%)
M.Cap ( in Cr)
169.56
Shareholding Pattern More
PROMOTERS 46.07 %
MUTUAL FUNDS/UTI 22.76 %
NON-INSTITUTION 14 %
FI/BANKS/INSURANCE 1.64 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes